A recent study has found that semaglutide reduced heart muscle mass in both lean and obese mice, as well as in lab-grown ...
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 512.66% and ...
Other public health news is on: food safety tips amidst outbreaks; fentanyl in dolphins in the Gulf of Mexico; and more.
Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.
Europe's largest insurer expects earnings growth to accelerate in the next three years driven by its property and casualty division and promised to return three quarters of its net profit to ...
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...